AU499140B2 - Pharmaceutical preparations forthe treatment of coronary heart diseases - Google Patents

Pharmaceutical preparations forthe treatment of coronary heart diseases

Info

Publication number
AU499140B2
AU499140B2 AU10002/76A AU1000276A AU499140B2 AU 499140 B2 AU499140 B2 AU 499140B2 AU 10002/76 A AU10002/76 A AU 10002/76A AU 1000276 A AU1000276 A AU 1000276A AU 499140 B2 AU499140 B2 AU 499140B2
Authority
AU
Australia
Prior art keywords
pharmaceutical preparations
coronary heart
heart diseases
forthe treatment
forthe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU10002/76A
Other languages
English (en)
Other versions
AU1000276A (en
Inventor
P. R Imhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU1000276A publication Critical patent/AU1000276A/en
Application granted granted Critical
Publication of AU499140B2 publication Critical patent/AU499140B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10002/76A 1975-01-06 1976-01-05 Pharmaceutical preparations forthe treatment of coronary heart diseases Expired AU499140B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CHCH71/75 1975-01-06
CH7175 1975-01-06

Publications (2)

Publication Number Publication Date
AU1000276A AU1000276A (en) 1977-07-14
AU499140B2 true AU499140B2 (en) 1979-04-05

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10002/76A Expired AU499140B2 (en) 1975-01-06 1976-01-05 Pharmaceutical preparations forthe treatment of coronary heart diseases

Country Status (14)

Country Link
JP (1) JPS5191337A (es)
AU (1) AU499140B2 (es)
BE (1) BE837293A (es)
CA (1) CA1063516A (es)
DE (1) DE2600069A1 (es)
FR (1) FR2296430A1 (es)
GB (1) GB1510370A (es)
HK (1) HK49680A (es)
IE (1) IE42766B1 (es)
IL (1) IL48785A (es)
MY (1) MY8100159A (es)
NL (1) NL7600045A (es)
NZ (1) NZ179623A (es)
ZA (2) ZA7628B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (es) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Also Published As

Publication number Publication date
ZA7626B (en) 1976-12-29
GB1510370A (en) 1978-05-10
CA1063516A (en) 1979-10-02
AU1000276A (en) 1977-07-14
IE42766L (en) 1976-07-06
IL48785A (en) 1978-08-31
BE837293A (fr) 1976-07-05
NZ179623A (en) 1978-03-06
FR2296430A1 (fr) 1976-07-30
MY8100159A (en) 1981-12-31
JPS5191337A (es) 1976-08-10
ZA7628B (en) 1976-12-29
HK49680A (en) 1980-09-12
DE2600069A1 (de) 1976-07-15
IE42766B1 (en) 1980-10-08
IL48785A0 (en) 1976-03-31
FR2296430B1 (es) 1978-11-10
NL7600045A (nl) 1976-07-08

Similar Documents

Publication Publication Date Title
IE38602L (en) Aryloxyalkanolamine derivatives
GB1540441A (en) Treatment of blood plasma
AU496814B2 (en) Process forthe preparation of antitumorigenic substances
AU499140B2 (en) Pharmaceutical preparations forthe treatment of coronary heart diseases
ZA763081B (en) Pharmaceutical preparations for the treatment of hyperuricacidemia
JPS5215813A (en) Preparation of stable medicine including homopyrimidazole derivative for aural administration
AU506773B2 (en) Compositions for treatment of cardiac rhythm disturbance
SU638339A1 (ru) Способ лечени сосудистых заболеваний конечностей
CA989731A (en) Treatment of heart diseases
JPS5271898A (en) Improvement of blood dialyzer
AU514653B2 (en) Pharmaceutical preparations forthe treatment of disorders in calcium metabolism
AU515852B2 (en) Burial casket
ZA782149B (en) Improved derivatives of 6,7-benzo-morphane,process for their preparation,and pharmaceutical preparations thereof
AU483541B2 (en) Treatment of peripheral vascular diseases
AU283197B2 (en) Pharmaceutical compositions forthe treatment of prophylayis of heart diseases
AU6429774A (en) Treatment of peripheral vascular diseases
AU3835163A (en) Pharmaceutical compositions forthe treatment of prophylayis of heart diseases
JPS5279595A (en) Improvement of blood dialyzer
AU499840B2 (en) Treatment of wood
AU498467B2 (en) Treatment of seeds
AU495067B2 (en) Heart pacemaker
AU495399B2 (en) Heart pacemaker
AU493057B2 (en) Methods and pharmaceutical preparations forthe treatment of hypercholesterolaemia
AU1014676A (en) Heart pacemaker
AU1014776A (en) Heart pacemaker